PivotalPath’s Head of Research, Mark Doherty, recently spoke to Bloomberg about the opportunity set for healthcare hedge fund managers.
The key takeaway? Healthcare long/short managers will continue to offer allocators compelling opportunities in 2020, particularly in the face of election year volatility.
In recent months, we’ve analyzed healthcare fundsat length, providing investors with both strategy and manager-level insights. Through October 2019, the PivotalPath Healthcare Index remains the top-ranked of 40+ indices, outperforming all other hedge fund strategies over 2, 5, and 10-year rolling periods.